Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Anthrax
- Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study
- BARDA Securing Anthrax Immunity For the Elderly
- Special Drug Use Investigation of Ciproxan Injection in Pediatrics
- Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed
- Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers
- Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
- Ciprofloxacin BioThrax Co-Administration Study
- A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109
- Single Dose, Weight-Based, Dose-Escalation Study With Intravenous ETI-204 in Adult Volunteers
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
- Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects
- Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults
- Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9)
- Ph1 Study of Valortim and Doxycycline in Humans
- Ph1 Study of Valortim and Ciprofloxacin in Humans
- Monoclonal Antibody for Treatment of Inhalation Anthrax
- Anthrax Vaccine Clinical Trials
- Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin